Acceleron Pharma Inc - Company Profile
Powered by
All the data and insights you need on Acceleron Pharma Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Acceleron Pharma Inc Strategy Report
- Understand Acceleron Pharma Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Acceleron Pharma Inc patents, including inventor and filing insights.
Patent Trends
Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
---|---|---|---|---|
WO2022192411A1 | Application | ACTRII-ALK4 ANTAGONISTS AND METHODS OF TREATING HEART FAILURE | September 15, 2022 | |
WO2022192420A2 | Application | ACTRII PROTEINS AND USES THEREOF | September 15, 2022 | |
WO2022192404A1 | Application | ACTRII-ALK4 ANTAGONISTS AND METHODS OF TREATING HEART FAILURE | September 15, 2022 | |
EP4054617A1 | Application | BEHANDLUNGEN FÜR SYSTEMISCHE SKLEROSE | A61K38/179; A61P11/00; A61P37/00; C07K14/495; C07K14/71; C07K2319/30 | September 14, 2022 |
CN104548056B | Grant | 活化素-ACTRIIA拮抗剂和促进癌症患者骨骼生长的用途 | A61K2039/505; A61K38/179; A61K38/1796; A61K38/18; A61K39/39558; A61K45/06; A61P13/12; A61P19/00; A61P19/08; A61P19/10; A61P21/00; A61P35/00; A61P35/04; A61P43/00; A61P5/14; A61P5/18; C07K14/4702; C07K14/71; C07K16/3061; C07K19/00; C07K2317/21; C07K2317/24; C07K2317/31; C07K2317/54; C07K2317/55; C07K2317/622; C07K2319/02; C07K2319/30; H04L2212/00; H04W40/00; H04W8/082; H04W80/04; H04W84/18 | September 09, 2022 |
Top Inventors by Filings (Count by publication)
Name | Count |
---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward